IFP Advisors’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,000
Closed -$7.18K – 5247
2026
Q2
$7.18K Buy
12,000
+4,000
+50% +$3.84K ﹤0.01% 3580
2026
Q1
$10.6K Sell
8,000
-3,000
-27% -$3.8K ﹤0.01% 3116
2025
Q4
$12.2K Sell
11,000
-1,000
-8% -$1.79K ﹤0.01% 2957
2025
Q3
$24.8K Buy
12,000
+2,000
+20% +$5.6K ﹤0.01% 2472
2025
Q2
$19.6K Buy
10,000
+7,000
+233% +$12.7K ﹤0.01% 2556
2025
Q1
$5.19K Buy
3,000
+2,000
+200% +$3.79K ﹤0.01% 2830
2024
Q4
$2.08K Buy
+1,000
New +$2.39K ﹤0.01% 3092
2024
Q3
– Sell
-1,000
Closed -$3.13K – 3327
2024
Q2
$3.13K Sell
1,000
-12,000
-92% -$41.7K ﹤0.01% 2712
2024
Q1
$19.6K Buy
+13,000
New +$53.4K ﹤0.01% 1978
2023
Q4
– Sell
-500
Closed -$1.11K – 3090
2023
Q3
$1.11K Hold
500
– – ﹤0.01% 2982
2023
Q2
$2.66K Buy
+500
New +$3.2K ﹤0.01% 2782
2023
Q1
– Sell
-600
Closed -$73K – 3532
2022
Q4
$73K Sell
600
-350
-37% -$6.45K ﹤0.01% 1960
2022
Q3
$114K Buy
950
+400
+73% +$12.1K ﹤0.01% 1764
2022
Q2
$67K Hold
550
– – ﹤0.01% 1950
2022
Q1
$67K Buy
+550
New +$33K ﹤0.01% 1949

Other funds holding CELU

IFP Advisors's CELU Position: Q3 2026 in Review

IFP Advisors sold out of Celularity (CELU) in Q3 2026, closing a stake of 12,000 shares — an estimated $7.18K sold.

IFP Advisors first reported a position in CELU in Q1 2022 and held it in 15 quarters. The position peaked at $114K in Q3 2022. 12 funds tracked by Wall St. Rank hold CELU as of Q3 2026.

  • IFP Advisors reported no remaining Celularity position as of Q3 2026 after selling out during the quarter.
  • IFP Advisors sold 12,000 Celularity shares in Q3 2026, an estimated $7.18K.
  • IFP Advisors first reported a position in Celularity in Q1 2022 and held it in 15 quarters.
  • IFP Advisors's Celularity position peaked at $114K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Celularity as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.